|
|
 | Vinpocetine significantly decreases the decline in the release of Dopamine that normally occurs in tandem with the progression of the Aging Process. research |
| Vinpocetine (10 mg per day) improves the flexibility of Red Blood Cells and may thereby help to prevent Strokes (a reduction in the flexibility of Red Blood Cells is associated with an increased risk of Stroke). research |
| Vinpocetine improves Blood Circulation to the Brain and thereby prevents and alleviates Cerebral Insufficiency. research |
| Vinpocetine improves impaired Hearing (Deafness) in many cases (e.g. in some cases of sudden hearing loss): research | ||
| |||
| Vinpocetine improves many Inner-Ear problems. | ||
 | Vinpocetine alleviates the symptoms of Meniere’s Disease. research | ||
| Vinpocetine alleviates Tinnitus. research | ||
| Vinpocetine alleviates Vertigo (dizziness) in 77% of patients. |
| Vinpocetine improves the condition of Age-Related Macular Degeneration (ARMD) patients (primarily by improving Blood Circulation to the Eyes). research |
| Vinpocetine improves Blood Circulation to the Eyes (especially to the Retina and Macula regions). research |
| Vinpocetine helps to stabilize the condition of Glaucoma patients. research |
| Vinpocetine improves Sight in many people afflicted with Eyesight Disorders (especially where impaired Sight occurs as a result of sub-optimal Blood Circulation to the Eyes). research |
 | Vinpocetine prolongs survival during periods of Anoxia (i.e. during the total absence of Oxygen). research | ||
| Vinpocetine possesses Antioxidant properties (it is comparable to Vitamin E in terms of its Antioxidant potential): research | ||
| |||
| Vinpocetine alleviates Fatigue (where the underlying cause of Fatigue is Cerebral Insufficiency). research |
| Vinpocetine increases the production of Adenosine Triphosphate (ATP) within the Brain's Neurons. | ||||||
| Vinpocetine increases Alertness (by improving Glucose and Oxygen utilization in the Brain). research | ||||||
| Vinpocetine may prevent and help to treat Alzheimer’s Disease. | ||||||
| Vinpocetine helps to prevent Amnesia (by improving Blood Circulation and Oxygen delivery to the Brain). research | ||||||
| Vinpocetine reduces Anxiety (where Anxiety is caused by Cerebral Insufficiency). research | ||||||
| Vinpocetine improves Blood Circulation within the Brain (i.e. it alleviates Cerebral Insufficiency by selectively dilating the Arteries of the Brain (the Cerebral Arteries)) and alleviates many of the side-effects (especially Mental Function) of people affected by Cerebral Insufficiency. research | ||||||
| Vinpocetine improves the function of the Noradrenergic Neurons located in the Brain Stem. research | ||||||
| Vinpocetine reduces Confusion (especially in people affected by Cerebral Insufficiency). research | ||||||
| Vinpocetine prevents and treats Multiple Infarct Dementia. research | ||||||
| Vinpocetine (10 mg per day) alleviates Depression in 74% of cases (especially where the underlying cause of Depression is Dementia or Cerebral Insufficiency). research | ||||||
| Vinpocetine reduces excessive Fear (where excessive Fear is caused by Cerebral Insufficiency). research | ||||||
| Vinpocetine alleviates Headaches in 78% of patients. | ||||||
| Vinpocetine enhances the function of the Hippocampus: research | ||||||
| |||||||
| Vinpocetine improves the Brain's utilization of Oxygen and increases the resistance of Neurons to the damage that would otherwise be caused by Hypoxia (i.e. it increases the Brain’s tolerance to Hypoxia and promotes Oxygen transport into Brain tissue). research | ||||||
| Vinpocetine accelerates the rate of Learning by up to 40%. research | ||||||
| Vinpocetine improves the function of and increases the activity of the Noradrenergic Neurons located in the Locus Coeruleus (a region within the Brain Stem). research | ||||||
| Vinpocetine improves Memory in normal, healthy people: research | ||||||
| |||||||
| Vinpocetine improves Long-Term Memory. research | |||||||
| Vinpocetine protects Neurons from damage and may reverse some aspects of Neuron damage (due to the Antioxidant properties of Vinpocetine). research | ||||||
| Vinpocetine alleviates Speech Impairment in 55% of cases. | ||||||
| Vinpocetine prevents and treats Stroke (by improving the Brain’s use of Oxygen). research | ||||||
| Vinpocetine (20 - 40 mg per day for short term use only) alleviates Vertigo in some people. research | ||||||
| Vinpocetine alleviates several types of Sleep disorders: | ||
|
| The side-effects of Female Menopause respond well to Vinpocetine. research |
| Vinpocetine increases the Brain’s utilization of Glucose: research | ||
| |||
| Vinpocetine protects Hyaluronic Acid from damage (due to the Antioxidant effects of Vinpocetine). research |
| Vinpocetine enhances the Brain’s utilization of Oxygen. research |
| Vinpocetine significantly decreases the decline in the release of Dopamine that normally occurs in tandem with the progression of the Aging Process. research |
| Vinpocetine increases the Brain's turnover of Norepinephrine research |
| Vinpocetine increases the Brain's turnover of Serotonin. |
| Vinpocetine increases the Brain’s production of Adenosine Triphosphate (ATP). research |
 | Vinpocetine (15 mg per day) enhances the release of Oxygen from Hemoglobin. research |
| Vinpocetine helps to prevent damage to Neurons caused by exposure to excessive levels of Glutamic Acid (due to the Antioxidant properties of Vinpocetine). research |
 | Vinpocetine occasionally causes (transient) Hypotension (lowered Blood Pressure). |
| Vinpocetine can (rarely) cause (transient) Tachycardia. |
| Vinpocetine can (rarely) cause Dry Mouth. |
| People who are prone to Hypotension (low Blood Pressure) should reduce the recommended dosage and monitor their Blood Pressure whilst using Vinpocetine. |
| Vinpocetine should not be used by women during Pregnancy. |
 | Vinpocetine is very similar to the related Smart Drug, Vincamine. In fact, Vinpocetine is derived from Vincamine. Vinpocetine is more potent and more effective than Vincamine. |
| Vinpocetine is at least two times (and in some cases, up to four times) more potent than Vincamine for most therapeutic purposes. |
| Vinpocetine causes Hypotension less frequently than Vincamine. |
| Vinpocetine causes Dry Mouth less frequently than Vincamine. |
| The recommended dosage of Vinpocetine for healthy people is 5 - 10 mg per day: |
| |
| Although the recommended dosage of Vinpocetine for healthy people is lower, clinical trials have demonstrated that maximum Memory improvement in healthy people occurs at a daily dosage of 40 mg of Vinpocetine. |
| The therapeutic, experimental dosage of Vinpocetine for Alzheimer’s Disease patients is 10 - 20 mg (average 15 mg) per day: |
|
| The therapeutic, experimental dosage of Vinpocetine for Vertigo patients is 20 - 40 mg per day: |
|
| The therapeutic effects of Vinpocetine begin to manifest after two days of Vinpocetine use. |
| The full therapeutic benefits of Vinpocetine are often not derived until it has been used on a daily basis for 12 months. |
| Vinpocetine is available from some health food stores and mail order supplement companies (only in the USA) in the form of 5 mg capsules (combined with 375 mg Arginine and 180 mg Vitamin C). |
| Vinpocetine is available from some international mail order pharmacies in the form of 5 mg tablets. |
| Eburnamenine-14-carboxylic acid ethylester |
| Ethyl-apovincaminate |
| 3a, 16 a - apovincaminic acid-ethyl-ester |
| C22H26N2O2 |
| Periwinkle Derivatives |
| Vincamine |
Noradrenergic Neurons